This Week at the Food & Drug Administration — week of June 22, 2026

This week the FDA logged 11 actions, nearly all of them formal classifications that place specific medical devices into the lower-risk “Class II” category, which makes it easier for manufacturers to bring similar products to market. The list also includes a food-safety proposal to allow radiation treatment of raw wheat flour. Most of the week’s moves are administrative, but several affect products ordinary people may encounter directly — infant sleep aids, pregnancy-risk blood tests, and tests for past coronavirus infection.

Sleep safety for infants

• The FDA classified infant supine sleep systems — devices that keep a baby flat on its back, such as the SNOO Smart Sleeper — as Class II medical devices. The classification sets clear expectations about securement and positioning, aimed at reducing the risk of sudden infant death syndrome or injuries from improper use. It also lowers regulatory hurdles for companies making these products, potentially speeding new options to market.

Monitoring risk during pregnancy

• A specific blood test for preeclampsia, the B·R·A·H·M·S sFlt-1/PlGF KRYPTOR Test System, was classified as Class II. The test measures proteins to assess the risk of developing or worsening preeclampsia during pregnancy. Moving it out of the default high-risk category means future manufacturers can use a simpler 510(k) notification process rather than full premarket approval, and it establishes special controls such as labeling and practitioner training requirements.

Faster answers for infections

• A rapid test that detects secreted proteins from Bacillus species — the family that includes the bacteria responsible for anthrax — was classified as Class II. The change lets manufacturers bring similar tests to market more efficiently while keeping safety requirements like labeling and performance verification.
• SARS-CoV-2 serology tests, which detect antibodies indicating a past coronavirus infection rather than an active one, were classified as Class II. This sets the review and labeling standard for future antibody tests, allowing companies to market substantially equivalent tests through a simpler notification process.

New pathways for chronic-condition treatments

• An external lower extremity nerve stimulator for Restless Legs Syndrome was classified as Class II, meaning standard safety rules plus specific extra controls are sufficient. The move reduces regulatory burden for manufacturers and could speed access to new treatments.
• A computerized behavioral therapy device for fibromyalgia symptoms was classified as Class II. Manufacturers can now use the 510(k) path instead of the more expensive, time-consuming premarket approval required for Class III devices.

Tools for surgeons and hospitals

• Endoscopic traction devices, used in complex gastrointestinal procedures, were classified as Class II. The change lowers the barrier to entry, which could lead to more options for surgeons, with indirect benefit to patients.
• An endoscopic light-projecting measuring device, which projects light onto tissue to measure features like polyps or lesions, was classified as Class II. It also becomes a “predicate,” giving future manufacturers a benchmark for safety reviews.
• A breast implant suction retrieval system was classified as Class II, clarifying the rules for this surgical tool and potentially reducing red tape and costs for future versions.
• Foam or gel disinfectants used to clean medical instruments were classified as Class II. The FDA set specific safety rules manufacturers must follow, giving them a clearer path to market without changing how hospitals use the products.

A possible change in how flour is processed

• The FDA received a proposal from Sterigenics U.S., LLC, to allow ionizing radiation to be used on raw enriched wheat flour to reduce harmful bacteria such as Salmonella or E. coli. If approved, it would give processors a chemical-free option for pathogen control, but the change is not in effect; it is at the proposal stage.

---

This weekly agency digest is generated from federal records (the Federal Register and Congress.gov) and summarized in plain English. It may simplify or omit detail — follow the linked official sources before relying on any item. Part of The Boring Parts.